Tianzhi International Accounting Firm (Special General Partnership) Special Instructions on Matters Related to the 2023 Annual Report Supervision Work Letter of Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical's Reply Notice on the Shanghai Stock Exchange's “Information Disclosure and Supervision Work Letter on the 2023 Annual Report of Kangmei Pharmaceutical Co., Ltd.”
Kangmei Pharmaceutical's announcement on receipt of court enforcement ruling
Kangmei Pharmaceutical's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of Kangmei Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Guangdong Cinda Law Firm on the 2023 Annual General Meeting of Shareholders of Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical's 2024 First Quarter Report
Announcement of Resolutions of the Second Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Announcement of Resolutions of the Second Interim Meeting of the 9th Board of Supervisors of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical's 2023 Annual General Meeting of Shareholders Meeting Materials
Tianji International Accounting Firm (Special General Partnership) on Kangmei Pharmaceutical Audit Report (2023)
Kangmei Pharmaceutical's 2023 Independent Director Debriefing Report (Luo Tao)
Announcement of Resolutions of the Fifth Meeting of the 9th Board of Directors of Kangmei Pharmaceutical
Rules of procedure for the board of directors of Kangmei Pharmaceutical Co., Ltd. (April 2024)
Kangmei Pharmaceutical Co., Ltd. Independent Director System (April 2024)
Kangmei Pharmaceutical Co., Ltd. Board Audit Committee Implementation Rules (April 2024)
Kangmei Pharmaceutical Co., Ltd. Board Nomination Committee Implementation Rules (April 2024)
Kangmei Pharmaceutical Co., Ltd. Board Remuneration and Assessment Committee Implementation Rules (April 2024)
Special evaluation opinion of the board of directors of Kangmei Pharmaceutical on the independence of independent directors in 2023
Kangmei Pharmaceutical's assessment report on the performance of accounting firms in 2023
No Data